加载中…
我们覆盖的 50 家公司，其中 48 家已评级
这里每家公司都经过同样的五项成长与现金创造检验。它描述的是这个行业今天申报出来的样子——而不是该买其中哪一家。
| ISRG | Intuitive Surgical, Inc. | A+ | US$143.1B | US$405.18 | 46.47 | US$11B | 28.4% |
| BDX | BECTON, DICKINSON AND COMPANY | B | US$50.1B | US$183.82 | 55.37 | US$23.3B | 4.0% |
| RMD | ResMed Inc. | B+ | US$32B | US$222.00 | 21.28 | US$5.7B | 26.9% |
| ALC | Alcon Inc. | B | US$31.4B | US$64.47 | 32.56 | US$9.5B | 10.3% |
| MDLN | Medline Inc. | C | US$29.2B | US$34.70 | 24.25 | US$28.4B | 4.1% |
| WST | WEST PHARMACEUTICAL SERVICES, INC. | B+ | US$26.1B | US$370.44 | 47.43 | US$3.3B | 17.0% |
| SOLV | SOLVENTUM CORPORATION | F+ | US$15.2B | US$89.50 | 10.95 | US$8.3B | 17.3% |
| BAX | BAXTER INTERNATIONAL INC. | D- | US$12.1B | US$23.37 | — | US$11.5B | -9.3% |
| RGEN | REPLIGEN CORP | A | US$10.7B | US$189.68 | 259.84 | US$785.1M | 5.3% |
| COO | The Cooper Companies, Inc. | A | US$10.5B | US$55.38 | 18.97 | US$4.2B | 13.5% |
| ALGN | ALIGN TECHNOLOGY, INC. | A | US$10.4B | US$146.78 | 25.57 | US$4.1B | 10.0% |
| AVTR | Avantor, Inc. | F | US$10.4B | US$15.25 | — | US$6.6B | -8.4% |
| ATR | AptarGroup, Inc | A | US$7.9B | US$123.87 | 22.36 | US$3.9B | 9.2% |
| STVN | Stevanato Group S.p.A. | C | US$6.4B | US$21.13 | 36.41 | US$1.4B | 11.0% |
| BLCO | Bausch & Lomb Corp | A- | US$6B | US$16.86 | — | US$5.3B | -3.2% |
| MMED | MiniMed Group, Inc. | D- | US$5.6B | US$19.98 | — | US$3.1B | -10.0% |
| MMSI | MERIT MEDICAL SYSTEMS INC | B | US$5.2B | US$87.50 | 36.01 | US$1.6B | 9.2% |
| TFX | TELEFLEX INCORPORATED | C | US$5.2B | US$122.07 | — | US$2.3B | -45.8% |
| ICUI | ICU MEDICAL INC/DE | C | US$4.1B | US$164.95 | 138.61 | US$2.2B | 0.0% |
| NVST | ENVISTA HOLDINGS CORPORATION | A | US$3.8B | US$23.95 | 41.29 | US$2.9B | 3.3% |
| PLSE | Pulse Biosciences, Inc. | D- | US$3.7B | US$51.63 | — | US$1.2M | -6,755.8% |
| WRBY | Warby Parker Inc. | B | US$3.4B | US$26.71 | 381.57 | US$911.6M | 0.8% |
| ATRC | AtriCure, Inc. | A | US$3B | US$58.38 | 278.00 | US$569.6M | 1.9% |
| BLFS | BioLife Solutions, Inc. | A+ | US$1.9B | US$38.49 | 32.90 | US$102.8M | 56.4% |
| XRAY | DENTSPLY SIRONA Inc. | D- | US$1.9B | US$9.40 | — | US$3.6B | -15.0% |
| LMAT | LEMAITRE VASCULAR, INC. | B+ | US$1.9B | US$81.52 | 28.60 | US$262.4M | 25.0% |
| KMTS | Kestra Medical Technologies, Ltd. | D- | US$1.6B | US$27.14 | — | US$106.7M | -140.4% |
| AZTA | AZENTA, INC. | C- | US$1.5B | US$34.02 | — | US$613.8M | -20.0% |
| STAA | STAAR Surgical Co | C | US$1B | US$20.51 | 256.38 | US$339.6M | 1.1% |
| ANGO | AngioDynamics, Inc. | B- | US$640.2M | US$15.49 | — | US$320.2M | -11.5% |
| EMBC | EMBECTA CORP. | D | US$334.3M | US$5.90 | 4.01 | US$1B | 8.6% |
| SMTI | SANARA MEDTECH INC. | A- | US$322.1M | US$35.06 | — | US$109.8M | -29.2% |
| ZJYL | Jin Medical International Ltd. | F | US$299M | US$1.91 | 191.00 | US$20.7M | 5.8% |
| NNNN | Anbio Biotechnology | B+ | US$275.1M | US$6.30 | 42.86 | US$8.6M | 74.1% |
| OSUR | ORASURE TECHNOLOGIES, INC | F- | US$271M | US$3.93 | — | US$112.4M | -43.7% |
| UTMD | UTAH MEDICAL PRODUCTS, INC. | F+ | US$236.2M | US$74.18 | 22.62 | US$36.1M | 29.0% |
| PDEX | PRO-DEX, INC. | A+ | US$229.9M | US$71.77 | 17.46 | US$77.5M | 17.6% |
| KRMD | KORU MEDICAL SYSTEMS, INC. | A- | US$148.2M | US$3.21 | — | US$45.1M | -4.0% |
| STXS | STEREOTAXIS, INC. | F- | US$130.3M | US$1.30 | — | US$30.1M | -74.2% |
| POCI | PRECISION OPTICS CORPORATION, INC. | D- | US$50.7M | US$4.63 | — | US$28.9M | -17.0% |
| DXR | Daxor Corporation | 未评级 | US$46.2M | US$11.01 | — | US$1.4M | -496.8% |
| NEPH | NEPHROS, INC. | C | US$45.9M | US$4.23 | 26.44 | US$20.7M | 8.4% |
| MLSS | MILESTONE SCIENTIFIC INC. | C- | US$36.4M | US$0.41 | — | US$9.4M | -44.0% |
| HBIO | HARVARD BIOSCIENCE, INC. | F- | US$36.2M | US$7.96 | — | US$87.8M | -11.9% |
| RVP | RETRACTABLE TECHNOLOGIES INC | F- | US$21M | US$0.70 | — | US$33.9M | -9.9% |
| BNGO | Bionano Genomics, Inc. | D- | US$19.5M | US$1.66 | — | US$30.2M | -106.6% |
| FEMY | Femasys Inc. | C- | US$8.3M | US$2.48 | — | US$2.3M | -511.8% |
| CUPR | Cuprina Holdings (Cayman) Limited | F- | US$4.8M | US$1.87 | — | US$39K | -9,366.8% |
| NXGL | NEXGEL, INC. | B- | US$1.7M | US$0.17 | — | US$12.1M | -51.3% |
| RGNT | Regentis Biomaterials Ltd. | 未评级 | US$1.1M | US$1.98 | 1.15 | — | — |
基本面来自 SEC 申报文件，价格来自最近一次行情更新。可按任意列排序；没有数值的公司在两个方向都排在末尾。
按市值从大到小排序；点击任意列可重新排序。没有数值的公司在两个方向都排在末尾，因为市盈率缺失意味着亏损，而不是便宜。这里没有任何内容构成推荐。